BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Chubb
Deloitte
US Army
Argus Health
Johnson and Johnson
Julphar
Accenture
AstraZeneca
Daiichi Sankyo

Generated: January 21, 2018

DrugPatentWatch Database Preview

Tygacil Drug Profile

« Back to Dashboard

Which patents cover Tygacil, and what generic alternatives are available?

Tygacil is a drug marketed by Pf Prism Cv and is included in one NDA. There are five patents protecting this drug and one Paragraph IV challenge.

This drug has fifty-eight patent family members in twenty-eight countries.

The generic ingredient in TYGACIL is tigecycline. There are ten drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the tigecycline profile page.
Summary for Tygacil
Drug patent expirations by year for Tygacil
Pharmacology for Tygacil

US Patents and Regulatory Information for Tygacil

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 AP RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 AP RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 AP RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 AP RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 AP RX Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Tygacil

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 ➤ Subscribe ➤ Subscribe
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 ➤ Subscribe ➤ Subscribe
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 ➤ Subscribe ➤ Subscribe
Pf Prism Cv TYGACIL tigecycline POWDER;IV (INFUSION) 021821-001 Jun 15, 2005 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for TYGACIL
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe For Injection 50 mg per vial ➤ Subscribe 6/15/2009

International Patents for Tygacil

Supplementary Protection Certificates for Tygacil

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0244 Netherlands ➤ Subscribe PRODUCT: TIGECYCLINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF METAALCOMPLEX, IN HET BIJZONDER TIGECYCLINE; FIRST REGISTRATION, DATE: EU/1/06/336/001, 20060424
00244 Netherlands ➤ Subscribe PRODUCT: TIGECYCLINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF METAALCOMPLEX, IN HET BIJZONDER TIGECYCLINE; FIRST REGISTRATION, DATE: EU/1/06/336/001, 20060424
C0031 France ➤ Subscribe PRODUCT NAME: TIGECYCLINE; REGISTRATION NO/DATE: EU/01/06/336/001 20060424
C/GB06/033 United Kingdom ➤ Subscribe PRODUCT NAME: TIGECYCLINE
06/030 Ireland ➤ Subscribe PRODUCT NAME: TIGECYCLINE OR A PHARMACOLOGICALLY ACCEPTABLE ORGANIC OR INORGANIC SALT OR METAL COMPLEX THEREOF; REGISTRATION NO/DATE: EU/1/06/336/001 20060424
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cantor Fitzgerald
US Army
McKesson
Moodys
Julphar
Colorcon
Deloitte
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot